Furuhata Yasufumi, Nishihara Masugi, Takahashi Michio
Department of Veterinary Physiology, Veterinary Medical Science, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
Nutr Res Rev. 2002 Dec;15(2):231-44. doi: 10.1079/NRR200243.
Growth hormone (GH) is an endocrine regulator of glucose and lipid metabolism as well as body growth. GH levels are decreased and a unique pulsatile secretory pattern becomes obvious after puberty particularly in males. Coincidentally with this, males tend to deposit body fat. Experimental and clinical evidence has accumulated that obesity is associated with a decrease in GH levels. A strain of transgenic rats has been generated with severe obesity but normal nose-to-tail length, which has low circulating GH levels without pulsatility (human growth hormone (hGH) transgenic rats). The present review mainly focuses on recent and current work analysing the relationship between the occurrence of obesity and low GH levels and/or the absence of GH pulsatility in this transgenic animal model. This model has elevated blood glucose, non-esterified fatty acid, insulin and leptin levels associated with hyperphagia, suggesting that these rats also carry insulin- and leptin-resistant characteristics. hGH transgenic rats were subjected to a pair-feeding treatment to normalize food intake and chronic GH replacement to normalize GH levels. While the pair-feeding for 8 weeks successfully suppressed body-weight gain, the fat pad : body weight ratio remained very similar to freely-eating control hGH transgenic rats, which indicates the hyperphagia is not the sole contributor to the excess fat accumulation in this model. However, continuous elevation of peripheral hGH levels (approximately 2-fold) for 8 weeks by means of a slow-release vehicle resulted in a significant decrease in the fat mass : body weight ratios by 30 %. This GH treatment altered neither food intake nor body-weight gain. Thus, two characteristic phenotypes observed in the hGH transgenic rats, hyperphagia and obesity, seem to be closely related to GH levels and GH secretory pattern. This relationship might be working in the regulation of changes in seasonal body composition in wild animals.
生长激素(GH)是葡萄糖和脂质代谢以及身体生长的内分泌调节因子。青春期后,尤其是男性,GH水平下降,独特的脉冲分泌模式变得明显。与此同时,男性往往会积累身体脂肪。实验和临床证据表明,肥胖与GH水平降低有关。已培育出一种严重肥胖但鼻尾长度正常的转基因大鼠品系,其循环GH水平低且无脉冲性(人生长激素(hGH)转基因大鼠)。本综述主要关注近期和当前的研究工作,分析该转基因动物模型中肥胖的发生与低GH水平和/或GH脉冲性缺失之间的关系。该模型血糖、非酯化脂肪酸、胰岛素和瘦素水平升高,伴有食欲亢进,表明这些大鼠也具有胰岛素抵抗和瘦素抵抗特征。对hGH转基因大鼠进行配对喂养以使其食物摄入量正常化,并进行慢性GH替代以使其GH水平正常化。虽然8周的配对喂养成功抑制了体重增加,但脂肪垫与体重的比值与自由进食的对照hGH转基因大鼠非常相似,这表明食欲亢进不是该模型中脂肪过度积累的唯一原因。然而,通过缓释载体使外周hGH水平持续升高(约2倍)8周,导致脂肪量与体重的比值显著降低30%。这种GH治疗既未改变食物摄入量,也未改变体重增加。因此,在hGH转基因大鼠中观察到的两种特征性表型,即食欲亢进和肥胖,似乎与GH水平和GH分泌模式密切相关。这种关系可能在野生动物季节性身体组成变化的调节中起作用。